Live from the NIH registry
Studies recruiting near Lakewood right now
Top 25 of 1,604 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Children's Hospital Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: University of Michigan
UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 45 participants sought
Children's Hospital Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Children's Hospital Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: Nationwide Children's Hospital
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
University of Colorado Anschutz Medical Campus — Denver, Colorado (7.6 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
Neuromyelitis Optica Spectrum Disorder, Pregnancy Related
N/A
Observational 60 participants sought
University of Colorado Denver — Aurora, Colorado (15.3 mi)
· Sponsor: Amgen
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: National Cancer Institute (NCI)
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
SCRI Denver Drug Development Unit — Denver, Colorado (7.6 mi)
· Sponsor: Acepodia Biotech, Inc.
Type 1 Diabetes REst for Metabolic Health
Type 1 Diabetes (T1D), Sleep Health
N/A
Interventional 50 participants sought
Children's Hospital Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Colorado Denver — Aurora, Colorado (15.3 mi)
· Sponsor: Jaeb Center for Health Research
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Denver, Colorado (7.6 mi)
· Sponsor: Dren Bio
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Children's Hospital of Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: St. Jude Children's Research Hospital
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Epithelioid Hemangioendothelioma (EHE)
Phase 2
Interventional 41 participants sought
University of Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: Sarcoma Alliance for Research through Collaboration
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Ovarian Cancer
Phase 1
Interventional 285 participants sought
Sarah Cannon Research Institute at HealthONE /ID# 278785 — Denver, Colorado (7.6 mi)
· Sponsor: AbbVie
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
Colorado Blood Cancer Institute /ID# 280275 — Denver, Colorado (7.6 mi)
· Sponsor: AbbVie
Effects of GLP-1 RAs on Human Lactation Outcomes
Lactation, Weight Loss
N/A
Observational 18 participants sought
University of Colorado Anschutz School of Medicine — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis
N/A
Observational 380 participants sought
Children'S Hospital of Colorado — Denver, Colorado (7.6 mi)
· Sponsor: University of Colorado, Denver
Longitudinal Study of Intra-Uterine Growth Restriction
IUGR, Pregnancy
N/A
Observational 200 participants sought
University of Colorado Denver Anschutz Medical Campus — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver
Alveolar Macrophage Programming Following Endotoxin Exposure
ARDS, Human
N/A
Interventional 25 participants sought
National Jewish Health — Denver, Colorado (7.6 mi)
· Sponsor: National Jewish Health
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
Phase 2
Interventional 38 participants sought
Children's Hospital Colorado — Aurora, Colorado (15.3 mi)
· Sponsor: Nationwide Children's Hospital
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Rheumatoid Arthritis, Interstitial Lung Disease
N/A
Observational 450 participants sought
University of Colorado Denver — Aurora, Colorado (15.3 mi)
· Sponsor: University of Colorado, Denver
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Denver, Colorado (7.6 mi)
· Sponsor: Sameek Roychowdhury
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Denver, CO — Denver, Colorado (7.6 mi)
· Sponsor: Mediar Therapeutics
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
Colorado Blood Cancer Institute — Denver, Colorado (7.6 mi)
· Sponsor: Lyell Immunopharma, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Barbara Davis Center for Childhood Diabetes — Aurora, Colorado (15.3 mi)
· Sponsor: Medtronic MiniMed, Inc.
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Rocky Mountain Cancer Centers — Lone Tree, Colorado (15.9 mi)
· Sponsor: Immuneering Corporation